Connective Capital Management, LLC
Position in OTLK — Outlook Therapeutics, Inc.
CIK 1543568
PALO ALTO, CA
Position in OTLK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$41,200
New position
Shares Held
200,000
first reported quarter
Ownership
0.082%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connective Capital Management, LLC holds $959,269 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PYPD |
PolyPid Ltd.
|
67,600 | $343,408 | |
| 2 | NNVC |
Nanoviricides, Inc.
|
185,217 | $255,599 | |
| 3 | ONCY |
Oncolytics Biotech Inc
|
185,712 | $176,426 | |
| 4 | PCSA |
Processa Pharmaceuticals, Inc.
|
85,274 | $163,726 | |
| 5 | HCWB |
HCW Biologics Inc.
|
3,338 | $16,656 | |
| 6 | LSTA |
Lisata Therapeutics, Inc.
|
1,016 | $3,454 |
All Filings in OTLK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,200 | 200,000 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||